Pharmacological modification of tumor blood flow: Lack of correlation between alteration of mean arterial blood pressure and changes in tumor perfusion

This publication has 37 references indexed in Scilit:

• Nicotinamide, Fluosol DA and Carbogen: a strategy to reoxygenate acutely and chronically hypoxic cells in vivo
  British Journal of Cancer, 1991
• Manipulation of oxygenation in a human tumour xenograft with BW12C or hydralazine : effects on responses to radiation and to the bioreductive cytotoxicity of misonidazole or RSU-1069
  Radiotherapy and Oncology, 1989
• Induction of severe tumor hypoxia by modifiers of the oxygen affinity of hemoglobin
  International Journal of Radiation Oncology*Biology*Physics, 1989
• Flavone acetic acid (LM-975; NSC-347512) activation to cytotoxic species in vivo and in vitro
  Cancer Chemotherapy and Pharmacology, 1989
• The effect of hydralazine on the tumor cytotoxicity of the hypoxic cell cytotoxin RSU-1069: Evidence for therapeutic gain
  International Journal of Radiation Oncology*Biology*Physics, 1987
• Factors involved in the anti-cancer activity of the investigational agents LM985 (flavone acetic acid ester) and LM975 (flavone acetic acid)
  British Journal of Cancer, 1987
• The Effect of Several Different Anaesthetics on the Blood Pressure and Heart Rate of the Mouse and on the Radiation Response of the Mouse Sarcoma RIF-1
  International Journal of Radiation Biology, 1985
• Abnormal Response of Tumor Vasculature to Vasoactive Drugs23
  JNCI Journal of the National Cancer Institute, 1984
• Vascular occlusion and tumour cell death
  European Journal of Cancer and Clinical Oncology, 1983
• Theoretical feasibility of vasodilator-enhanced local tumor heating
  European Journal of Cancer and Clinical Oncology, 1982